Inicio › Enfermedad de células falciformes › Ohio
Ensayos clínicos de Enfermedad de células falciformes en Ohio
22 estudios sobre Enfermedad de células falciformes buscan participantes en Ohio.
Ciudades en Ohio
Texto oficial del estudio (inglés)
A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)
- Cincinnati Children's Hospital Medical Center, Cincinnati
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 23 sept 2026 · NCT07187973A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
- Univ Hosp Cleveland Med Ctr, Cleveland
- Ohio State Univ Wexner Med Ctr, Columbus
ReclutandoFase 3
Edades de 12 en adelante · Todos los sexos · Actualizado el 17 sept 2026 · NCT06612268Sickle Cell Disease Biofluid Chip Technology (SCD BioChip)
- University Hospitals Case Medical Center, Cleveland
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 12 en adelante · Todos los sexos · Actualizado el 11 sept 2026 · NCT02824471A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
- Local Institution - 0028, Cleveland
ReclutandoFase 1/2Se aceptan voluntarios sanos
Edades de 18 en adelante · Todos los sexos · Actualizado el 18 ago 2026 · NCT06481306ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Akron Children's Hospital - Showers Center for Cancer & Blood Disorders, Akron
- Cincinnati Children's Hospital Medical Center, Hemophilia & Thrombosis Center, Cincinnati
- University of Cincinnati Medical Center Hemophilia Treatment Center, Cincinnati
- y 5 más
ReclutandoEstudio observacional
Todas las edades · Todos los sexos · Actualizado el 17 ago 2026 · NCT04398628Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
- University of Cincinnati, Cincinnati
- The Ohio State University, Columbus
ReclutandoFase 2
Edades de 12 en adelante · Todos los sexos · Actualizado el 14 ago 2026 · NCT06699849Integrative Medicine in Pain Management in Sickle Cell Disease, 2.0
- University of Cincinnati College of Medicine, Cincinnati
ReclutandoSe aceptan voluntarios sanos
Edades de 14 a 80 · Todos los sexos · Actualizado el 12 ago 2026 · NCT06725550Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)
- Ohio State University, Columbus
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 ago 2026 · NCT07224360Gene Correction in Autologous CD34+ Hematopoietic Stem Cells (HbS to HbA) to Treat Severe Sickle Cell Disease
- Nationwide Children's Hospital, Columbus
ReclutandoFase 1/2
Edades de 12 a 50 · Todos los sexos · Actualizado el 2 jul 2026 · NCT04819841Hydroxyurea Exposure Limiting Pregnancy and Follow-Up Lactation
- Cincinnati Children's Hospital Medical Center, Cincinnati
ReclutandoEstudio observacional
Todas las edades · Todos los sexos · Actualizado el 18 jun 2026 · NCT04093986Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
- Nationwide Children's Hospital (NT-DMT), Columbus
ReclutandoEstudio observacional
Edades de 3 a 20 · Todos los sexos · Actualizado el 4 jun 2026 · NCT06941389A Socio-ecological Approach for Improving Self-management in Adolescents With SCD
- Cincinnati Children's Hospital Medical Center, Cincinnati
Reclutando
Edades de 13 a 21 · Todos los sexos · Actualizado el 11 may 2026 · NCT06290401Delivering Patient-Facing Evidence-Based Guidelines Through mHealth to Adults With Sickle Cell Disease
- The Ohio State University Medical Center, Columbus
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 23 mar 2026 · NCT06919224Zinc Supplementation in Sickle Cell Disease: A Precursor to the Think Zinc for Bones Trial
- Cincinnati Children's Hospital, Cincinnati
ReclutandoFase 2
Edades de 15 a 40 · Todos los sexos · Actualizado el 13 mar 2026 · NCT06260891Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease
- Nationwide Children's Hospital, Columbus
ReclutandoFase 2
Edades de 2 a 25 · Todos los sexos · Actualizado el 10 mar 2026 · NCT03587272MULTIsite Feasibility of MUSIc Therapy to Address Quality Of Life in Sickle Cell Disease
- UH Seidman Cancer Center Adult SCD Clinic or UH Rainbow Babies and Children's Hospital Sickle Cell Anemia Center, Cleveland
Reclutando
Edades de 14 en adelante · Todos los sexos · Actualizado el 29 ene 2026 · NCT06853158A Long-term Follow-up Study in Patients Who Received BEAM-101
- University Hospitals Clevland Medical Center, Cleveland
- The Clevland Clinic Foundation, Cleveland
ReclutandoEstudio observacional
Edades de 14 a 37 · Todos los sexos · Actualizado el 28 ene 2026 · NCT07373639Verifying Antibodies After Live Immunization Delivery (VALID): A Study of Measles Vaccine Immunogenicity in Children With Sickle Cell Disease
- Cincinnati Children's Hospital Medical Center, Cincinnati
ReclutandoEstudio observacional
6 Months – 6 Years · Todos los sexos · Actualizado el 21 ene 2026 · NCT07356050Integrative Training Program for Pediatric Sickle Cell Pain
- Cincinnati Children's Hospital Medical Center, Cincinnati
Reclutando
Edades de 12 a 18 · Todos los sexos · Actualizado el 14 nov 2025 · NCT06691867Effectiveness of Nontraditional Hydroxyurea Algorithms: Novel and Clinical Evaluations (ENHANCE)
- Cincinnati Children's Hospital Medical Center, Cincinnati
ReclutandoFase 4
6 Months · Todos los sexos · Actualizado el 16 sept 2025 · NCT07177300HPC Offered for PRESERVE Expansion
- The Ohio State University Medical Center, Columbus
ReclutandoEstudio observacional
Edades de 12 a 80 · Todos los sexos · Actualizado el 28 ago 2025 · NCT07145411Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease
- Cleveland Clinic, Cleveland
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 jun 2025 · NCT06385886De ClinicalTrials.gov, datos obtenidos el 30 sept 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.